Investors
Within a year of its inception, ActoGeniX raised €20 million through a Series A equity round, one of the largest among European biotech start-ups. Our syndicate of experienced life sciences investors includes companies such as GIMV, Biotech Fund Flanders and Baekeland Fund (Belgium), Life Science Partners and Aescap (The Netherlands) and Ventech (France).
 |
 |
 |
 |
 |
 |
-
14/05/2008
-
04/02/2008
-
12/07/2007
ActoGeniX receives EUR 3 million from the Flanders government through IWT.